FP 300
Alternative Names: FP-300Latest Information Update: 24 Nov 2023
At a glance
- Originator Flightpath Biosciences
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Research Endometriosis
Most Recent Events
- 10 Oct 2023 FP 300 is available for licensing as of 10 Oct 2023. https://flightpath.bio/pipeline/
- 10 Oct 2023 Early research in endometriosis in USA (unspecified route) (Flightpath biosciences pipeline, October 2023)